[Combretastatin A4 phosphate].
Verdier-Pinard
P
P
Screening Technologies Branch, National Cancer Institute, NCI-Frederick, PO Box B, Bldg 469, Room 140, Frederick, Maryland 21702, Etats-Unis.
Lansiaux
A
A
Bailly
C
C
D000818:Animals; D000972:Antineoplastic Agents, Phytogenic / Q000737:chemistry / Q000494:pharmacology*; D001632:Bibenzyls / Q000737:chemistry / Q000494:pharmacology*; D002986:Clinical Trials as Topic; D004353:Drug Evaluation, Preclinical; D006801:Humans; D051379:Mice; D009369:Neoplasms / Q000098:blood supply / Q000188:drug therapy; D009389:Neovascularization, Pathologic / Q000188:drug therapy; D021281:Quantitative Structure-Activity Relationship; D051381:Rats; D013267:Stilbenes; D014183:Transplantation, Heterologous
D000972:Antineoplastic Agents, Phytogenic; D001632:Bibenzyls; D013267:Stilbenes; C040105:combretastatin